Related Experiment Video
Updated: May 8, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Correlation between CHADS2 score and anticoagulant use in atrial fibrillation: Results of a mini-survey
Gerry Cartman1, Mark Blostein, Mark J Eisenberg
1Department of Professional Services, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec.
Insights
Higher CHADS2 scores correlate with increased anticoagulant use in atrial fibrillation patients. Unexpectedly high anticoagulation in low-risk patients was linked to cardioversion, where rhythm control decreased with higher CHADS2 scores.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Quality assurance in atrial fibrillation (AF) management hinges on appropriate anticoagulation.
- The CHADS2 score is a standard tool for stratifying thromboembolic risk and guiding anticoagulation decisions.
Purpose of the Study:
- To investigate the correlation between increasing thromboembolic risk (CHADS2 score) and the rate of anticoagulant prescription in AF patients.
- To explore anticoagulation patterns in low-risk patients and their relationship with cardioversion.
- To examine the association between CHADS2 score and rhythm control success during cardioversion.
Main Methods:
- A mini-survey was conducted to assess anticoagulant prescription rates.
- Correlation coefficients (r) were calculated to quantify relationships between variables.
- Analysis included subgroup examination of cardioverted patients.
Main Results:
- A significant positive correlation (r=0.8) was observed between CHADS2 score and anticoagulant prescription rates.
- Anticoagulant use was higher than anticipated in patients with a CHADS2 score of 0.
- In cardioverted patients, a strong negative correlation (r=-0.89) was found between CHADS2 score and the rate of successful rhythm control.
Conclusions:
- Anticoagulant prescribing generally aligns with thromboembolic risk as indicated by the CHADS2 score.
- Pre-cardioversion anticoagulation in low-risk AF patients contributes to higher-than-expected anticoagulant use.
- The inverse relationship between CHADS2 score and rhythm control success in cardioverted patients warrants further research.
Abstract:
Quality assurance in atrial fibrillation is related to the appropriate use of anticoagulation. The CHADS2 score is widely used to determine which patients should or should not be anticoagulated. The authors hypothesized that as thromboembolic risk and, therefore, the CHADS2 score increases, so should the rate of anticoagulant prescription. The authors found a positive correlation between CHADS2 score and anticoagulant prescription (r=0.8) in a mini-survey. Although anticoagulant use at CHADS2 score = 0 was presumed to be very low, it was found to be higher than expected. This was readily explained by a group of low-risk patients being anticoagulated before cardioversion. Cardioverted patients were then examined as a group and it was found that the rate of rhythm control decreased with CHADS2 score (r= -0.89), a finding that has not been reported in the literature and may warrant further investigation.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Assessment of blood pressure in brachial artery(two-step method)
